HOME >> MEDICINE >> NEWS
New Mayo Clinic MRI technology enables noninvasive liver diagnoses

ROCHESTER, Minn. -- Two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases. The findings will be presented this week at the International Society for Magnetic Resonance in Medicine Annual Meeting in Berlin, Germany, and Digestive Disease Week 2007 in Washington, D.C.

The liver responds to many diseases that damage its cells by developing scar tissue or fibrosis. MRE uses a modified form of magnetic resonance imaging (MRI) to accurately measure the hardness or elasticity of the liver. By applying vibrations to the liver, MRE obtains pictures of the mechanical waves passing through the organ. The wave pictures are then processed to generate a quantitative image of tissue stiffness.

"Healthy liver tissue is very soft, while a liver with fibrosis is firmer, and a liver with cirrhosis is almost rock-hard," says Richard Ehman, M.D., lead researcher on the MRE project. "If detected early, fibrosis of the liver can be treated, but once the disease has progressed to cirrhosis, the condition is irreversible."

Dr. Ehman and his imaging research team collaborated with Mayo Clinic gastroenterologists to study whether MRE could provide reliable and accurate diagnoses in patients with varying degrees of liver disease.

One study involved MRE examinations of 57 individuals with chronic liver disease and 20 healthy volunteers. The researchers confirmed that MRE accurately detects fibrosis with high sensitivity and specificity. Researchers also found that steatosis, which is deposits of fatty acids and triglycerides in liver cells and a common condition in patients with liver disease, did not interfere with detection of fibrosis with MRE.

"Based on this research, we are now using MRE examinations in select patients to determine liver stiffness and assess the need for liver biopsies," sa
'"/>

Contact: Elizabeth Rice
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
22-May-2007


Page: 1 2

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
6. Elsevier launches the Clinics on ScienceDirect
7. Clinical guidelines for blood conservation during cardiac procedures developed
8. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
9. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
10. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
11. Clinical trial coordinators need more financial conflict-of-interest training

Post Your Comments:
(Date:5/20/2013)... Durham, N.C. (PRWEB) May 20, 2013 ... Training Institute (IFPTI), will speak at North Carolina Food ... Food is Good Business: The Need for Partnerships – ... , The two-day conference, scheduled for May 22-23 at ... role partnerships across the food sector have in protecting ...
(Date:5/19/2013)... California has one of the largest pool of ... discovering that comprehensive background checks are playing an important role ... Driving records can paint an accurate portrait of a ... any DUI arrests, speeding offenses, and traffic violations to their ... to experience 4SafeDrivers.com, a new online service which allows users ...
(Date:5/19/2013)... Houston,TX (PRWEB) May 20, 2013 Due ... companies with online advertising, MileageAds.com has decided to invite ... advertisements through their ad network. , Businesses in ... of success with online marketing, specifically with ad networks. ... advice, information and legal services and are unsure where ...
(Date:5/19/2013)... of the heterogeneity the variety of genetic mutations ... of patients with the most common type of head and ... journal Cancer , investigators at Massachusetts General Hospital (MGH) ... was a better predictor of survival than most traditional risk ... carcinoma of the head and neck. , "Our ...
(Date:5/19/2013)... The American Gastroenterological Association (AGA) Research Foundation ... recipients. The awards are intended to stimulate interest ... school, undergraduate, graduate and medical school students. The ... and Edythe Broad Foundation. , "The AGA ... unprecedented research opportunities," said Nicholas F. LaRusso, MD, ...
Breaking Medicine News(10 mins):Health News:IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference 2Health News:4SafeDrivers.com Announces Driving Record Searches for California Employers 2Health News:Mileageads Ad Network Now Invites Bloggers and Business Owners in Mesothelioma Sector to Advertise on Their Ad Network 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 2Health News:Genetic diversity within tumors predicts outcome in head and neck cancer 3Health News:AGA Student Research Fellowships enable 30 young investigators to further their research careers 2
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation (NYSE: ... the annual EuroPCR Scientific Program May 21-24 in ... to present a particularly rich and diversified set of ... Dawkins , M.D., global chief medical officer, Boston ... be presented, including the NG PROMUS trial, which evaluated ...
(Date:5/16/2013)... , May 16, 2013  Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: ... Conference on Tuesday, May 21, 2013, at the Sheraton New ... , beginning at 10:00 a.m. Eastern Daylight Time. ... of Research and Development at Amgen, will present at the ... the Events Calendar on Amgen,s website, www.amgen.com , under ...
Breaking Medicine Technology:Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
Cached News: